Clearly Nasrat has a PPS in mind in which he will sell the store lock stock and barrel. And I would argue he won't get that PPS currently and thus the poison pill. Further, I would argue a BP isn't going to touch Elite at this point in time regarding a buyout. So, a better line of discussion, in my mind at least, is at what point does Elite stand a solid chance of being bought out - meaning what will it take for a BP to put a number in front of Nasrat to make him consider bringing this PPS to shareholders for a vote?
I would argue Elite does not stand a chance in getting bought out until Eli 200 has launched and the next 2 ADT opioids have been NDA filed and Elite has a BP marketing and sales partnership in place.
Let us start here - clearly continuing this discussion is not merely academic and likely to be fruitful.
Bring the noise N2k
News 
Market Data 
Discover 
